Rapport Therapeutics, Inc. (RAPP) expects to raise $136 million in an initial public offering (IPO) on Friday, June 7th, IPO Scoop reports. The company will be issuing 8,000,000 shares at $16.00-$18.00 per share. Rapport Therapeutics, Inc. has a market cap of $601.4 million. Goldman Sachs, Jefferies, TD Cowen and Stifel served as the underwriters for […]

Related Keywords

California , United States , San Francisco , Delaware , Boston , Massachusetts , David Bredt , Eli Lilly , News Ratings For Rapport Therapeutics Inc , University Of California , Goldman Sachs , Rapport Therapeutics Inc , Rapport Therapeutics , Third Rock Ventures , Chief Scientific Officer , Global Head , Neuroscience Discovery , Janssen Pharmaceutica , Vice President , Janssen License ,